ImaRx Schedules Release of First Quarter 2008 Financial Results
May 07 2008 - 5:41PM
PR Newswire (US)
Live Webcast and Conference Call Scheduled for Tuesday, May 13th at
5 PM ET TUCSON, Ariz., May 7 /PRNewswire-FirstCall/ -- ImaRx
Therapeutics, Inc. (NASDAQ:IMRX) today announced that the Company
will host a live webcast and conference call on Tuesday, May 13,
2008, at 5:00 p.m. ET to discuss first quarter 2008 financial
results. The live webcast can be accessed through ImaRx's corporate
website at http://www.imarx.com/ and will be archived on the
website for 14 days following the event. Interested parties may
access the conference call by dialing (877) 407-4018 in the U.S.
and Canada or (201) 689-8471 internationally. A telephonic replay
will be available through May 20, 2008 by dialing (877) 660-6853 in
the U.S. and Canada or (201) 612-7415 internationally (Account
Number 3055 and Conference ID 284385). About ImaRx Therapeutics
ImaRx Therapeutics is a biopharmaceutical company developing and
commercializing therapies for vascular disorders. The Company's
research and development efforts are focused on therapies for
stroke and other vascular disorders using its proprietary
microbubble technology. The Company's commercialization efforts are
currently focused on its product, urokinase, for the treatment of
acute massive pulmonary embolism. Contacts: The Ruth Group
(Investors/Media) Sara Ephraim/Jason Rando 646-536-7002 or 7025
DATASOURCE: ImaRx Therapeutics, Inc. CONTACT: Investors and Media:
Sara Ephraim, , Jason Rando, , +1-646-536-7002 or 7025, both of The
Ruth Group, for ImaRx Therapeutics, Inc. Web site:
http://www.imarx.com/
Copyright
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Jul 2023 to Jul 2024